In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response to neo-adjuvant chemotherapy in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer Meeting Abstract


Authors: Soliman, H. H.; Robson, M. E.; Wagner, S.; Flake, D. D.; Schwartzberg, L. S.; Sharma, P.; Magliocco, A. M.; Kronenwett, R.; Lancaster, J. M.; Lanchbury, J. S.; Gutin, A.; Gradishar, W. J.
Abstract Title: In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response to neo-adjuvant chemotherapy in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 17s
Language: English
ACCESSION: WOS:000442916000048
DOI: 10.1200/JCO.2018.36.15_suppl.539
PROVIDER: wos
Notes: Meeting Abstract: 539 -- Source: Wos
Altmetric Score
MSK Authors
  1. Mark E Robson
    355 Robson